2003
DOI: 10.1080/714044797
|View full text |Cite
|
Sign up to set email alerts
|

A Theoretical Model for Utilizing Mammalian Pharmacology and Safety Data to Prioritize Potential Impacts of Human Pharmaceuticals to Fish

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

7
277
1
3

Year Published

2006
2006
2021
2021

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 278 publications
(288 citation statements)
references
References 27 publications
7
277
1
3
Order By: Relevance
“…If these plasma concentrations in fish are compared with human therapeutic doses (C max ) [26], then L. megalotis plasma levels of diphenhydramine, diltiazem and carbamazepine were 17, 190 and 490 lower than human C max values, respectively (electronic supplementary material, table S5). Huggett et al [26] previously proposed that if pharmaceuticals occur in fish plasma within a factor of 1000 (based on three separate safety factors of 10 for mammalian to non-mammalian species -species differences and human to animal extrapolations) from the human therapeutic dose then these chemicals deserve additional study. Bioaccummulation of diltiazem and carbamazepine was previously reported from a similar study in Sweden [24].…”
Section: Results and Discussion (A) Traditional Water Chemistry Measumentioning
confidence: 99%
“…If these plasma concentrations in fish are compared with human therapeutic doses (C max ) [26], then L. megalotis plasma levels of diphenhydramine, diltiazem and carbamazepine were 17, 190 and 490 lower than human C max values, respectively (electronic supplementary material, table S5). Huggett et al [26] previously proposed that if pharmaceuticals occur in fish plasma within a factor of 1000 (based on three separate safety factors of 10 for mammalian to non-mammalian species -species differences and human to animal extrapolations) from the human therapeutic dose then these chemicals deserve additional study. Bioaccummulation of diltiazem and carbamazepine was previously reported from a similar study in Sweden [24].…”
Section: Results and Discussion (A) Traditional Water Chemistry Measumentioning
confidence: 99%
“…However, for most human and many veterinary drugs, insights as to possible effects in the environment can be gleaned from existing data collected to determine drug efficacy and human-health safety (2,3,25,26). Pharmaceuticals are developed purposely to affect specific biological pathways (and, hopefully, not others) in target species.…”
Section: Testing Pharmaceuticals For Ecological Effectsmentioning
confidence: 99%
“…The majority of currently available bioaccumulation models specifically developed for IOCs in fish are regression-based [9][10][11][12], although an equilibrium partitioning approach considering the role of sorption to proteins was recently proposed to characterize the bioaccumulation potential of some PFAAs [13]. Generic methods for estimating the tissue-plasma partitioning of IOCs have also been described in the literature [14,15].…”
Section: Introductionmentioning
confidence: 99%